These Biotech Stocks Could Get “Let Out Of The Cage” This Year
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
“In such a volatile market, it is quite difficult to find reasonably safe and high-growth biotech stocks,” acknowledges the author of today’s article. Of course,…
No matter what happens to the economy, people aren’t going to stop taking their prescription medications. As a result, the author of today’s article suggests…
In volatile times such as these, investors tend to seek refuge in so-called safe-haven assets such as U.S. Treasury bonds and precious metals. As the…
“When investing becomes dangerous what are your best choices?” This is the question that the author of today’s article poses – and proceeds to answer…
2017 saw near-record low stock market volatility. In 2018, however, the author of today’s article notes, “fear is back – and so are healthy prices…
Market volatility has been back with a vengeance – and it has been during periods of increased market volatility such as this that the author…
Against a backdrop of increased market volatility, interest in “safe haven” assets – including precious metals – is increasing. However, today’s article outlines how, “Despite…
The biggest – and seemingly indisputable – takeaway from the first three months of 2018, according to the author of today’s article? Volatility is back.…
Inflation concerns are rising – and not without good reason. Today’s article notes, for example, that the Consumer Price Index climbed more than expected in…